Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 10975790)

Published in Dig Liver Dis on March 01, 2000

Authors

M Koch1, A Dezi, M Tarquini, L Capurso

Author Affiliations

1: Department of Digestive Diseases & Nutrition, General Hospital S. Filippo Neri, Rome, Italy.

Articles by these authors

Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology (1995) 1.76

Early versus late surgery for ileo-caecal Crohn's disease. Aliment Pharmacol Ther (2007) 1.60

Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Dig Liver Dis (2005) 1.58

Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis? A meta-analysis of randomized controlled trials. Dig Liver Dis (2008) 1.49

Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Dig Liver Dis (2006) 1.42

Comparison of cimetidine 800 mg once daily and 400 mg twice daily in acute duodenal ulceration. Br Med J (Clin Res Ed) (1984) 1.30

Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther (1994) 1.22

Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol (1995) 1.15

Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Arch Intern Med (1996) 1.15

DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry (1998) 1.13

Mass movements and intracolonic pressures. Am J Dig Dis (1971) 1.11

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther (1995) 1.09

Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Aliment Pharmacol Ther (2007) 0.99

Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis (2008) 0.96

Severe ulcerative colitis, dural sinus thrombosis, and the lupus anticoagulant. Am J Gastroenterol (1995) 0.92

Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon. J Viral Hepat (2003) 0.92

Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther (2011) 0.92

Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol (1992) 0.92

Probiotics: from research to consumer. Dig Liver Dis (2006) 0.90

Adrenergic fibres in the human intestine. Gut (1968) 0.84

Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther (2000) 0.82

Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions. Cytometry (1984) 0.81

Long term treatment with omeprazole 20 mg three days a week or 10 mg daily in the prevention of duodenal ulcer relapse. Aliment Pharmacol Ther (1994) 0.79

Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists. Dig Dis (1995) 0.78

[Is it possible to use sex ratio at birth as indicator of the presence of endocrine disrupters in environmental pollution?]. G Ital Med Lav Ergon (2004) 0.78

Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients. Am J Gastroenterol (1990) 0.77

Distribution of 5-OH tryptamine (serotonin) in ulcerative colitis. Proc R Soc Med (1970) 0.77

Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. Eur Rev Med Pharmacol Sci (2017) 0.77

Activity of epomediol in the treatment of hepatopathies: a double-blind multi-centre study. J Int Med Res (1987) 0.76

Laxative consumption in chronic nonorganic constipation. J Clin Gastroenterol (1987) 0.76

Effects of guar gum, ispaghula and microcrystalline cellulose on abdominal symptoms, gastric emptying, orocaecal transit time and gas production in healthy volunteers. Dig Liver Dis (2002) 0.76

Omeprazole 20 or 40 mg daily for healing gastroduodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther (1998) 0.76

Eradicating Helicobacter pylori in non-ulcer dyspepsia may not be cost effective. BMJ (2001) 0.75

[Comparison of shift work and night shifts: impacts on health and wellbeing among sanitary workers]. G Ital Med Lav Ergon (2013) 0.75

[The otilonium bromide-benzodiazepine combination in the therapy of the irritable colon syndrome]. Clin Ter (1992) 0.75

[Pharmacologic study of the mechanical activity of the colonic mucosa in cats]. Arch Ital Mal Appar Dig (1969) 0.75

[Multi-institution, multidisciplinary radiology and endoscopy trial of the diagnostic accuracy of the double contrast examination of the stomach surface]. Radiol Med (1979) 0.75

[Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study]. Minerva Gastroenterol Dietol (1993) 0.75

Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine. J Crohns Colitis (2009) 0.75

Lansoprazole and Helicobacter pylori infection. Clin Ther (1993) 0.75

[Clinical morphology in chronic hepatitis: laparoscopy]. Minerva Med (1980) 0.75

[Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment]. Clin Ter (1984) 0.75

[Fluorescence of the 5-HT content of the human colonic mucosa]. Arch Ital Mal Appar Dig (1969) 0.75

Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial. Ital J Gastroenterol (1991) 0.75

[Routine double contrast examination of the stomach: results and considerations on personal experience (author's transl)]. Radiol Med (1979) 0.75

[Risk assessment in upper limb overload]. G Ital Med Lav Ergon (2008) 0.75

SIGE-AIGO proposals for assessing continued education and training in gastroenterology. Report of the SIGE-AIGO Working Group. Ital J Gastroenterol (1995) 0.75

Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? Minerva Gastroenterol Dietol (2008) 0.75

Potential prognostic significance of cytometrically determined DNA abnormality in GI tract human tumors. Ann N Y Acad Sci (1986) 0.75

Ménétrier's disease diagnosed by enteroclysis CT: a case report and review of the literature. Abdom Imaging (2011) 0.75

[Dyspepsia. Bayesian analysis of symptoms as an aid in clinical diagnosis]. Minerva Gastroenterol Dietol (1994) 0.75

[Study of pain due to distension of the ileum and of the large intestine in men]. Arch Ital Mal Appar Dig (1969) 0.75

[Irritable colon syndrome: therapeutic activity of otilonium bromide alone or in combination with benzodiazepine. Controlled double-blind study]. Clin Ter (1984) 0.75

Correlation of various Crohn's disease activity indexes in subgroups of patients with primarily inflammatory or fibrostenosing clinical characteristics. J Clin Gastroenterol (1996) 0.75

[New liver tests emerging from specialistic research. Determination of serum bile-salts]. Minerva Med (1980) 0.75

Cimetidine, 800 mg at night versus 400 mg twice daily, in the treatment of duodenal ulcer. Scand J Gastroenterol Suppl (1986) 0.75

Clinical evaluation of serum N-acetyl-beta-D-glucosaminidase as a liver function test. Biochem Med Metab Biol (1990) 0.75

A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse. Aliment Pharmacol Ther (1991) 0.75

CEA in gastric juice and chronic atrophic gastritis: a prospective evaluation. J Clin Gastroenterol (1993) 0.75

[Medical and dietetic therapy of cholesterol lithiasis]. Minerva Med (1980) 0.75

[Preliminary results of fluorescent histochemical studies of the catecholamine and 5-HT content of the intestinal wall in humans]. Arch Ital Mal Appar Dig (1969) 0.75

[Lansoprazole: an analysis of the clinical trials in the 3 years of 1997-1999]. Recenti Prog Med (2000) 0.75

[Assessment of risk of burden in construction: improvement interventions and contribution of the competent physician]. G Ital Med Lav Ergon (2013) 0.75

Effects of sulglycotide on inflammation and epithelial cell turnover in active Helicobacter pylori+ chronic gastritis. A pilot study. Dig Dis Sci (1996) 0.75

[Correlation of radiology, endoscopy and biopsy in the pathology of the gastric fundus]. J Radiol Electrol Med Nucl (1975) 0.75

Acute ischaemic colitis following intravenous cocaine use. Ital J Gastroenterol Hepatol (1999) 0.75

[Epidemiology and prevention of chronic hepatitis and cirrhosis]. Minerva Med (1980) 0.75